Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grubbs

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Oncogene|December 26, 2001
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitorY Wang, L Hu, R Yao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 11, 2011
Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancerYan Lu, Pengyuan Liu, Francoise Van den Bergh, et al.
Carcinogenesis|December 14, 2004
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosisRonald A Lubet, Konstantin Christov, Nomeli P Nunez, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2013
Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genesYan Lu, Ming You, Zara Ghazoui, et al.
Frontiers in Microbiology|October 26, 2020
Cycloheximide-Producing <i>Streptomyces</i> Associated With <i>Xyleborinus saxesenii</i> and <i>Xyleborus affinis</i> Fungus-Farming Ambrosia BeetlesKirk J Grubbs, Frank Surup, Peter H W Biedermann, et al.
Carcinogenesis|September 23, 1998
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer modelR A Lubet, V E Steele, R DeCoster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 18, 2012
The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathwayM Carla Cabrera, Edgar S Díaz-Cruz, Bhaskar V S Kallakury, et al.
Oncology Letters|September 21, 2017
Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancerMatthew D Thompson, Ronald A Lubet, David L Mccormick, et al.
Anticancer Research|March 12, 1998
Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancerS M Swanson, L M Whitaker, C R Stockard, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Oncogene|December 26, 2001
Altered gene expression profile in chemically induced rat mammary adenocarcinomas and its modulation by an aromatase inhibitorY Wang, L Hu, R Yao, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 11, 2011
Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancerYan Lu, Pengyuan Liu, Francoise Van den Bergh, et al.
Carcinogenesis|December 14, 2004
Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosisRonald A Lubet, Konstantin Christov, Nomeli P Nunez, et al.
Molecular Cancer Therapeutics|April 1, 2008
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changesRonald A Lubet, Eva Szabo, Konstantin Christov, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 27, 2013
Concordant effects of aromatase inhibitors on gene expression in ER+ Rat and human mammary cancers and modulation of the proteins coded by these genesYan Lu, Ming You, Zara Ghazoui, et al.
Frontiers in Microbiology|October 26, 2020
Cycloheximide-Producing <i>Streptomyces</i> Associated With <i>Xyleborinus saxesenii</i> and <i>Xyleborus affinis</i> Fungus-Farming Ambrosia BeetlesKirk J Grubbs, Frank Surup, Peter H W Biedermann, et al.
Carcinogenesis|September 23, 1998
Chemopreventive effects of the aromatase inhibitor vorozole (R 83842) in the methylnitrosourea-induced mammary cancer modelR A Lubet, V E Steele, R DeCoster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 18, 2012
The CDK4/6 inhibitor PD0332991 reverses epithelial dysplasia associated with abnormal activation of the cyclin-CDK-Rb pathwayM Carla Cabrera, Edgar S Díaz-Cruz, Bhaskar V S Kallakury, et al.
Oncology Letters|September 21, 2017
Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancerMatthew D Thompson, Ronald A Lubet, David L Mccormick, et al.
Anticancer Research|March 12, 1998
Hormone levels and mammary epithelial cell proliferation in rats treated with a regimen of estradiol and progesterone that mimics the preventive effect of pregnancy against mammary cancerS M Swanson, L M Whitaker, C R Stockard, et al.
Pageof 16